IP Library Granted Patent US 11,246,703
Granted Patent B2
US 11,246,703 · App. 16/894,715 · Granted Feb 15, 2022

Additive manufacturing inside the human eye

Inventor: Javier G. Gonzalez (Palo Alto, CA)
Assignee: AMO Development, LLC
A61F2/1662A61F9/0017A61F9/00812A61F9/00814A61F9/00825B29C64/135B29C64/153B29C64/30B29D11/00105B29D11/00134B33Y10/00B33Y40/00B33Y70/00B33Y80/00A61B2017/00154A61F9/00834A61F2009/0087A61F2009/00872A61F2009/00887A61F2009/00889A61F2210/0085A61F2240/001B29K2029/04B29K2033/12B29L2011/0016B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,246,703
App. No.
16/894,715
Granted
Feb 15, 2022
Kind
B2
Abstract

Additive manufacturing techniques are used to form an artificial intra-ocular lens (IOL) directly inside the human eye. Small openings are formed in the cornea and lens capsule of the eye, and the crystalline lens is broken up and removed through the openings; then, a material is injected into the lens capsule through the openings, and the focal spot of a pulse laser beam is scanned in a defined pattern in the lens capsule, to transform the material in the vicinity of the lase focal spot to form the IOL in a layer-by-layer manner. In one embodiment, stereolithography techniques are used where a pulse UV laser source is used to photosolidify a photopolymer resin. The liquefied resin is injected into the eye through the openings, after which only part of the resin, having the shape of the desired IOL, is selectively cured with the UV laser beam, via progressive layer formation.

Claims (9)

1. A method for forming an artificial intra-ocular lens (IOL) inside a patient's eye, comprising:

using a pulse laser beam from a laser system to form an opening in a cornea and an opening in a lens capsule of the patient's eye;

using the pulse laser beam from the laser system to break up a crystalline lens of the eye from the lens capsule;

removing the broken up crystalline lens through the openings in the cornea and the lens capsule;

injecting a material into the lens capsule through the openings in the cornea and the lens capsule; and

forming said artificial IOL directly inside the lens capsule by scanning a focal spot of the pulse laser beam from the laser system inside the lens capsule in a defined scanning pattern to transform the material in a vicinity of the focal spot of the pulse laser beam;

wherein the material includes unassembled individual slices of the IOL, wherein the injecting step includes incrementally injecting the individual slices into the lens capsule,

wherein the forming step includes scanning the focal spot of the pulse laser beam to incrementally assemble injected individual slices together, and

wherein the individual slices include slices of polymethylmethacrylate, and wherein the forming step includes scanning the focal spot of the pulse laser beam to melt surface layers of the polymethylmethacrylate slices.

Assignments (3)
MERGER Recorded Sep 24, 2020
From: OPTIMEDICA CORPORATION
To: AMO DEVELOPMENT, LLC
Reel/Frame 053877/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2020
From: GONZALEZ, JAVIER G.
To: OPTIMEDICA CORPORATION
Reel/Frame 052858/0870 →
MERGER Recorded Jun 5, 2020
From: OPTIMEDICA CORPORATION
To: AMO DEVELOPMENT, LLC
Reel/Frame 052859/0076 →
Continuity (3)
Division 15890153 · Feb 6, 2018
Provisional Application 62455445 · Feb 6, 2017
Related Publication 20200297480A1 · Sep 24, 2020